Research and Markets has announced the addition of the “The Worldwide Market for Molecular Diagnostics – 6-Month Update” report to their offering.
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest-growing segments of the diagnostics market.
Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.
{iframe}http://www.reuters.com/article/2014/03/31/research-and-markets-idUSnBw316430a+100+BSW20140331{/iframe}